Aurobindo Pharma
BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
LIVE
BSE
Feb 10, 15:59
110.65
-6.65 (-5.67%)VOLUME 955,145
LIVE
NSE
Feb 10, 17:00
110.65
-6.75 (-5.75%) VOLUME 4,007,598
Research Reports on Aurobindo Pharma
Buy Aurobindo Pharma; target Rs 166: Angel Broking
3.44 pm | 21 Nov 2011 | Source: Moneycontrol.com
Angel Broking is bullish on Aurobindo Pharma (APL) and has recommended buy rating on the stock with a target price of Rs 166 in its November 16, 2011 ...
1
Quick Links for Aurobindo Pharma
|
Related Searches
Aurobindo Pharma Stock Price, Aurobindo Pharm Stock Quote, Aurobindo Pharm Results , Aurobindo Pharm News ..
More »
Follow moneycontrol.com
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News |
Markets |
IPO |
Technicals |
Mutual Fund |
Commodities |
Best Portfolio Manager |
Bse Sensex |
Bombay Stock Exchange |
Share Market Live |
Recession 2011 |
Commodities Price |
Silver Price/Rate in India |
Gold Price/Rate in India |
Crude Oil |
USD to INR |
National Stock Exchange |
Bank Fixed Deposits |
Company Fixed Deposits |
Small Savings Schemes |
Property rates in India |
| Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide |
Bigg Boss Season 5
| History India | Davos
| Uninor | Indian Space Research Organisation | Aurobindo Pharma | Vodafone Essar | Bonus share | Suzlon Energy | Etisalat | Mark Zuckerberg | State Bank of India | Acropolis
| Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide |
Bigg Boss Season 5
| History India | Davos
| Uninor | Indian Space Research Organisation | Aurobindo Pharma | Vodafone Essar | Bonus share | Suzlon Energy | Etisalat | Mark Zuckerberg | State Bank of India | Acropolis
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.